Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383199049> ?p ?o ?g. }
- W4383199049 endingPage "S69" @default.
- W4383199049 startingPage "S62" @default.
- W4383199049 abstract "Abstract Background Our aim in this retrospective cohort study was to assess the impact on mortality of the empirical use of polymyxin as therapy for carbapenem-resistant gram-negative bacteria (CR-GNB) in septic patients. The study was performed at a tertiary academic hospital in Brazil, from January 2018 to January 2020, the pre–coronavirus disease 2019 period. Methods We included 203 patients with suspected sepsis. The first doses of antibiotics were prescribed from a “sepsis antibiotic kit”, which contained a selection of drugs, including polymyxin, with no preapproval policy. We developed a logistic regression model to assess risk factors associated with 14-day crude mortality. Propensity score for polymyxin was used to control biases. Results Seventy (34%) of 203 patients had infections with at least 1 multidrug-resistant organism isolated from any clinical culture. Polymyxins in monotherapy or in combination therapy were prescribed to 140 of the 203 (69%) patients. The overall 14-day mortality rate was 30%. The 14-day crude mortality was associated with age (adjusted odds ratio [aOR], 1.03; 95% confidence interval [CI], 1.01–1.05; P = .01), SOFA (sepsis-related organ failure assessment) score value (aOR, 1.2; 95% CI, 1.09–1.32; P < .001), CR-GNB infection (aOR, 3.94; 95% CI, 1.53–10.14; P = .005), and time between suspected sepsis and antibiotic administration (aOR, 0.73; 95% CI, .65–.83; P < .001). The empirical use of polymyxins was not associated with decreased crude mortality (aOR, 0.71; 95% CI, .29–1.71; P = .44). Conclusions Empirical use of polymyxin for septic patients in a setting with high CR-GNB prevalence was not associated with decreased crude mortality." @default.
- W4383199049 created "2023-07-06" @default.
- W4383199049 creator A5004194539 @default.
- W4383199049 creator A5022892800 @default.
- W4383199049 creator A5047734340 @default.
- W4383199049 creator A5049922792 @default.
- W4383199049 creator A5055506482 @default.
- W4383199049 creator A5084969130 @default.
- W4383199049 creator A5086979902 @default.
- W4383199049 creator A5087485658 @default.
- W4383199049 date "2023-07-01" @default.
- W4383199049 modified "2023-09-26" @default.
- W4383199049 title "Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort" @default.
- W4383199049 cites W1557253316 @default.
- W4383199049 cites W1891727612 @default.
- W4383199049 cites W1898928487 @default.
- W4383199049 cites W1993397663 @default.
- W4383199049 cites W2000445173 @default.
- W4383199049 cites W2017352107 @default.
- W4383199049 cites W2114604259 @default.
- W4383199049 cites W2150188452 @default.
- W4383199049 cites W2157720105 @default.
- W4383199049 cites W2162031798 @default.
- W4383199049 cites W2278600110 @default.
- W4383199049 cites W2280404143 @default.
- W4383199049 cites W2529736552 @default.
- W4383199049 cites W2581605534 @default.
- W4383199049 cites W2599245417 @default.
- W4383199049 cites W2607050795 @default.
- W4383199049 cites W2614741637 @default.
- W4383199049 cites W2745432684 @default.
- W4383199049 cites W2750165346 @default.
- W4383199049 cites W2790359941 @default.
- W4383199049 cites W2887873765 @default.
- W4383199049 cites W2911566892 @default.
- W4383199049 cites W2913131218 @default.
- W4383199049 cites W2989834448 @default.
- W4383199049 cites W2998853022 @default.
- W4383199049 cites W3015171124 @default.
- W4383199049 cites W3023757607 @default.
- W4383199049 cites W3094338265 @default.
- W4383199049 cites W3163870295 @default.
- W4383199049 cites W3203103016 @default.
- W4383199049 cites W4200036649 @default.
- W4383199049 cites W4200250437 @default.
- W4383199049 cites W4229924182 @default.
- W4383199049 cites W4307560961 @default.
- W4383199049 doi "https://doi.org/10.1093/cid/ciad272" @default.
- W4383199049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37406048" @default.
- W4383199049 hasPublicationYear "2023" @default.
- W4383199049 type Work @default.
- W4383199049 citedByCount "0" @default.
- W4383199049 crossrefType "journal-article" @default.
- W4383199049 hasAuthorship W4383199049A5004194539 @default.
- W4383199049 hasAuthorship W4383199049A5022892800 @default.
- W4383199049 hasAuthorship W4383199049A5047734340 @default.
- W4383199049 hasAuthorship W4383199049A5049922792 @default.
- W4383199049 hasAuthorship W4383199049A5055506482 @default.
- W4383199049 hasAuthorship W4383199049A5084969130 @default.
- W4383199049 hasAuthorship W4383199049A5086979902 @default.
- W4383199049 hasAuthorship W4383199049A5087485658 @default.
- W4383199049 hasBestOaLocation W43831990491 @default.
- W4383199049 hasConcept C126322002 @default.
- W4383199049 hasConcept C156957248 @default.
- W4383199049 hasConcept C167135981 @default.
- W4383199049 hasConcept C179755657 @default.
- W4383199049 hasConcept C2776685102 @default.
- W4383199049 hasConcept C2777628635 @default.
- W4383199049 hasConcept C2778384902 @default.
- W4383199049 hasConcept C2779259085 @default.
- W4383199049 hasConcept C2780675486 @default.
- W4383199049 hasConcept C44249647 @default.
- W4383199049 hasConcept C501593827 @default.
- W4383199049 hasConcept C71924100 @default.
- W4383199049 hasConcept C86803240 @default.
- W4383199049 hasConcept C89423630 @default.
- W4383199049 hasConceptScore W4383199049C126322002 @default.
- W4383199049 hasConceptScore W4383199049C156957248 @default.
- W4383199049 hasConceptScore W4383199049C167135981 @default.
- W4383199049 hasConceptScore W4383199049C179755657 @default.
- W4383199049 hasConceptScore W4383199049C2776685102 @default.
- W4383199049 hasConceptScore W4383199049C2777628635 @default.
- W4383199049 hasConceptScore W4383199049C2778384902 @default.
- W4383199049 hasConceptScore W4383199049C2779259085 @default.
- W4383199049 hasConceptScore W4383199049C2780675486 @default.
- W4383199049 hasConceptScore W4383199049C44249647 @default.
- W4383199049 hasConceptScore W4383199049C501593827 @default.
- W4383199049 hasConceptScore W4383199049C71924100 @default.
- W4383199049 hasConceptScore W4383199049C86803240 @default.
- W4383199049 hasConceptScore W4383199049C89423630 @default.
- W4383199049 hasIssue "Supplement_1" @default.
- W4383199049 hasLocation W43831990491 @default.
- W4383199049 hasLocation W43831990492 @default.
- W4383199049 hasLocation W43831990493 @default.
- W4383199049 hasOpenAccess W4383199049 @default.
- W4383199049 hasPrimaryLocation W43831990491 @default.
- W4383199049 hasRelatedWork W1126919609 @default.
- W4383199049 hasRelatedWork W2398800724 @default.